Paeijaet-Haemeen hyvinvointialue
- Address
- Keskussairaalankatu 7, 15850 Lahti, Finland
Päijät-Hämeen Hyvinvointialue Clinical Research Center
Päijät-Hämeen Hyvinvointialue is a prominent clinical research center in Finland conducting innovative trials across multiple therapeutic areas. The center demonstrates particular expertise in gastroenterology, rheumatology, and oncology, with a focus on advancing treatment strategies for complex chronic and life-threatening conditions.
- Inflammatory bowel disease research, including novel microbiome-based therapies combined with biologic treatments for ulcerative colitis and Crohn's disease
- Autoimmune and inflammatory conditions, particularly giant cell arteritis management with advanced immunomodulatory agents and glucocorticoid-sparing regimens
- Colorectal cancer research, focusing on population-based studies of metastatic disease behavior, surgical resectability, and patient outcomes
The center's research portfolio reflects a commitment to both cutting-edge therapeutic interventions and real-world clinical outcomes. Their work encompasses fecal microbiota transplantation protocols, Phase III biologic drug trials, and comprehensive population-based cancer registries, positioning them at the forefront of translational medicine in Finland.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1GlaxoSmithKline Biologicals1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Paeijaet-Haemeen hyvinvointialue
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparison of Intravenous Iohexol-Enhanced CT Versus Non-Contrast CT in Acute Abdomen Patients with Impaired Renal Function: A Multicenter Randomized Trial | University Of Helsinki | Phase III | Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 1 | Unknown | 2025-01-25 | 2025-01-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.